A systemic inflammatory response occurs during SARS-CoV2 infection and is associated
with hypercoagulability and thrombotic events. From March 2020 in our hospital different …

Background Critically ill COVID-19 patients have a clear pattern of inflammation and
hypercoagulable state. The main aim of the study was to evaluate the outcome of severe …

Background. A prothrombotic state, attributable to excessive inflammation, cytokine storm,
hypoxia, and immobilization, is a feature of SARS-CoV-2 infection. Up to 30% of patients …

Hypercoagulability is a common complication of the systemic inflammation related to
coronavirus disease 2019 creating debate within the critical care community on the …

Introduction In the first wave, thrombotic complications were common in COVID-19 patients.
It is unknown whether state-of-the-art treatment has resulted in less thrombotic complications …

Background Cardiovascular complications; myocardial infarction (MI), ischemic stroke, and
pulmonary embolism (PE), represent an important source of adverse outcomes in COVID-19 …

As patients with COVID-19 pneumonia admitted to intensive care unit (ICU) have high rates
of thrombosis, high doses of thromboprophylaxis have been proposed. The associated …

Background: Thrombotic complications of coronavirus disease 2019 (COVID-19) are a
worrisome aspect of the disease due to their high incidence in critically ill patients and their …

Elevated D-dimer and fibrinogen level, mild thrombocytopenia, modest prolongation of
prothrombin time, and activated partial thromboplastin time are key indicators of …

Background The association between coronavirus infection 2019 (COVID-19) and
thrombosis has been explicitly shown through numerous reports that demonstrate high rates …